Close Menu

NEW YORK – High-sensitivity troponin assays have made inroads in the US market in recent years, but according to some clinicians, the tests aren't as useful as they could be.

This is because the US Food and Drug Administration does not allow laboratories to return results down to their assays' limits of detection (LOD). Instead, hs-troponin results are reported down to the limit of quantitation (LOQ), which is typically higher than an assay's LOD, meaning that some potentially actionable information is not returned.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.